Navigation Links
MedNet Solutions Announces Latest Enhancements To Its iMedNet EDC eClinical Solution
Date:9/17/2012

MINNETONKA, Minn., Sept. 17, 2012 /PRNewswire/ -- MedNet Solutions, a global life sciences technology company specializing in clinical study management systems, is pleased to announce that the latest version of iMedNet EDC is now available.  iMedNet EDC is a ground-breaking eClinical solution that makes electronic data capture functionality practical for any type of research initiative...even very small studies of short duration.  This affordable Software-as-a-Service (SaaS) application provides an incredibly flexible toolset that allows sponsor and clinical research organization staff to quickly and easily build and manage their own studies.

Highlights of the latest iMedNet EDC release include:

  • Auto Coding – Automates the coding of free text terms using any dictionary (MedDRA, WHO Drug, etc.), while streamlining backend coder review and workflow.
  • iPRO™ – Delivers a timely, secure and easy-to-use mechanism to gather electronic patient reported outcomes (ePRO) information directly from study participants via the web.
  • Double Data Entry – Provides a flexible and efficient means to support centralized data entry and discrepancy resolution for paper-based research initiatives.

"Our latest iMedNet release further underscores our commitment to fully supporting the research needs of the life sciences community," remarked John M. (Rob) Robertson, President and CEO of MedNet Solutions. "iMedNet EDC is clearly 'hitting the mark' with sponsors and CROs alike.  They consistently tell me how impressed (and in some cases amazed) they are with iMedNet's ease of use, flexibility and low price point."

For more information on iMedNet EDC, or to schedule a system demonstration, please contact MedNet by email: contact@mednetstudy.com, by phone: (866) 258‐2735, or visit MedNet's website: www.mednetstudy.com.

About MedNet Solutions

MedNet Solutions is a leading healthcare technology company specializing in electronic data capture (EDC) and clinical trial management systems (CTMS) designed for the global life sciences market.  MedNet delivers proven, flexible and easy-to-use web-based eClinical solutions that effectively support clinical studies, registries and investigator initiated trials of all types and sizes.  Since 2000, MedNet has successfully supported pharmaceutical, medical device, biotechnology, and contract research organizations (CROs) on clinical research conducted around the world.  These companies trust MedNet to consistently deliver the technology innovation, experience and reliability they need for success.  For more information, please visit www.mednetstudy.com.

Contact Information:
Dirk H. Nelson
Director of Marketing
110 Cheshire Lane, Suite 300
Minnetonka, MN 55305
USA
(763) 258-2735


'/>"/>
SOURCE MedNet Solutions
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. MedNet Solutions to Demonstrate Its Innovative Suite of eClinical Solutions at the 2012 Bio-IT World Conference & Expo
2. uAttend Time Tracking Solutions Available at TimeClockDeals.com
3. Validity CTO to Present Natural ID Solutions for Improving Mobile Risk Management and User Experience at NFC Solutions Summit 2012
4. CDS Monarch Deploys DigitalPersona Strong Authentication Solutions for Secure Access to Electronic Medical Records
5. BioLife Solutions Announces 7th Consecutive Quarter of Record Revenue
6. University of Minnesota startup offers game-changing energy solutions that reduce CO2 emissions
7. Bowman provides strategies to engage public with climate change solutions
8. BioOne announces 2013 Collections
9. Aware Announces Sale of Selected Patents
10. Evermedia Group Announces 375% Increase in Revenue for Second Quarter 2012
11. American Health Assistance Foundation announces grants to advance promising vision research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... Florida , March 29, 2016 ... the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased ... in ink used in a variety of writing instruments, ... Buyers of originally created collectibles from athletes on LegacyXChange ... forensic analysis of the DNA. Bill ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... Brooklyn, NY (PRWEB) , ... June 24, 2016 , ... ... 15mm, machines such as the Cary 5000 and the 6000i models are higher end ... height is the height of the spectrophotometer’s light beam from the bottom of the ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology: